| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 1,070 | $60 | $62.2K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 1,680 | $40 | $60.3K |
| 90460 | In this procedure, the provider administers a single live attenuated vaccine through a parenteral, oral, intranasal, intramuscular, or intravenous to a patient up to 18 years of age. | 890 | $10 | $5.3K |
| 87426 | The lab analyst performs an immunoassay to qualitatively or semiquantitatively evaluate the patient blood specimen for antigens of severe acute respiratory syndrome coronavirus such as SARS–CoV–2,… | 110 | $30 | $3.8K |
| 99393 | The provider performs an established well–patient visit for a child who is between the ages of 5 and 11. | 50 | $60 | $3.1K |
| 0071A | N/A | 10 | $30 | $440 |
| 87430 | The lab analyst performs an assay to evaluate the patient’s sample for antigens to Streptococcus, group A, using an immunoassay method, such as EIA. | 30 | $10 | $270 |
| 87400 | The lab analyst performs the technical lab test to detect antigens of influenza A or B using an immunoassay technique, such as EIA. This analysis will distinguish if a patient has influenza A or B. | 30 | $10 | $200 |
| 99050 | In this procedure, the provider renders services to a patient in his office at a time when that office would otherwise be closed. | 10 | $10 | $70 |
| 90656 | This code represents a preservative–free trivalent influenza vaccine product containing split virus components. It is administered into the muscle in a 0.5 mL dosage. | 10 | $0 | $0 |